🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to evaluate safety/ reactogenicity of ...
Status
Completed
Location
Floridian Clinical Research LLC
Start Date
2023-05-17
Trial ID
NCT05901636
Treatments Being Tested
The pivotal Phase 3 trial plans to enroll a total of approximately 12,460 p...
Status
Completed
Location
Jagiellońskie Centrum Innowacji Sp.z o.o.
Start Date
2018-08-01
Trial ID
NCT03450915
"Multimeric-001" (M-001) has been recently developed, containing conserved,...
Status
Completed
Location
Hadassah medical center
Start Date
2011-08
Trial ID
NCT01419925
The goal of this clinical trial is to investigate the local delivery of min...
Status
Completed
Location
Enas Elgendy
Start Date
2023-05-20
Trial ID
NCT06997731
The primary and secondary objectives of this Phase 1 study are respectively...
Status
Completed
Location
Centre for Vaccinology (CEVAC)
Start Date
2020-09-07
Trial ID
NCT04519073
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of A...
Status
Completed
Location
University of Maryland School of Medicine - Center for Vaccine Development - Baltimore
Start Date
2019-07-08
Trial ID
NCT04009824
Treatments Being Tested
The purpose of this study is to assess the reactogenicity, safety and immun...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-08
Trial ID
NCT03275389
A double-blind, randomized, placebo-controlled, Phase I clinical study of t...
Status
Completed
Location
Federal State Budgetary Institution "Research Institute of Influenza" of the Ministry of Health of the Russian Federation
Start Date
2019-08-29
Trial ID
NCT04650971
The objective of the study is to determine if one 45-minute treatment with ...
Status
Completed
Location
Annex of Quantum Northwest Presents
Start Date
2009-09
Trial ID
NCT01130454
FLU-v is a vaccine that aims to protect against a wide range of flu viruses...
Status
Completed
Location
Isala
Start Date
2016-08
Trial ID
NCT02962908
Treatments Being Tested